The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Evaluation of the safety and effectiveness of cryoablation in the treatment of renal angiomyolipoma related to tuberous sclerosis complex: The Cryo-TSC.
 
Eiji Kashiwagi
No Relationships to Disclose
 
Takashi Hatano
No Relationships to Disclose
 
Kanichiro Shimiz
No Relationships to Disclose
 
Atsushi Takamoto
No Relationships to Disclose
 
Koji Tomita
No Relationships to Disclose
 
Takahiro Osawa
Honoraria - Takeda
 
Yusuke Sakuhara
No Relationships to Disclose
 
Fumiya Hongo
No Relationships to Disclose
 
Tatsuya Hirota
No Relationships to Disclose
 
Yasuhiro Ushijima
No Relationships to Disclose
 
Yoshiki Asayama
Other Relationship - Canon Medical System
 
Jun Miki
No Relationships to Disclose
 
Fumiaki Kiyomi
No Relationships to Disclose
 
Shin Egawa
Research Funding - Bayer (Inst); Kissei Pharmaceutical (Inst); Ono Pharmaceutical (Inst); Takeda (Inst)
 
Yasutomo Nasu
No Relationships to Disclose
 
Nobuo Shinohara
Research Funding - Astellas Pharma; Ono Pharmaceutical; Takeda
 
Osamu Ukimura
Consulting or Advisory Role - EDAP TMS
Research Funding - Boston Scientific (Inst)
Patents, Royalties, Other Intellectual Property - Kyosera
 
Shuji Nakano
No Relationships to Disclose
 
Yasuaki Arai
Consulting or Advisory Role - Boston Scientific; TERUMO
 
Masatoshi Eto
Consulting or Advisory Role - AstraZeneca; Bristol-Myers Squibb; Chugai Pharma; Eisai; Merck; Pfizer; Takeda
Speakers' Bureau - AstraZeneca; Bristol-Myers Squibb; Eisai; Merck; MSD; Ono Pharmaceutical; Takeda
Research Funding - Ono Pharmaceutical; Sanofi; Takeda